| http://www.w3.org/ns/prov#value | - Some therapeutic approaches involve conjugation of naked antibody to a toxin or radioisotope, such as the conjugation of Y91 or I131 to anti-CD20 antibodies (e.g., Zevalin???, IDEC Pharmaceuticals Corp. or Bexxar??? Coulter Pharmaceuticals), while others involve co-administration of antibodies and other therapeutic agents, such as Herceptin??? (trastuzumab) with paclitaxel (Genentech, Inc.).
|
